There are several ways in which the oral administration of prednisolone may be unsatisfactory:
(1) Once a therapeutic dose of prednisolone has been taken for several weeks, the sudden withdrawal of therapy may have unpleasant consequences. The great majority of patients will stick to the dose ordered, but there are occasions when they may not be able to do so. The commonest involuntary withdrawal occurs during gastro-intestinal upsets, especially those due to poisoning or infection from food, when the tablets may either be vomited or passed through too quickly to be absorbed. Accidents and operations may also lead to a reduction in or cessation of therapy just when a larger dose is necessary. If it were possible to give prednisolone as a depot injection that lasted for one or a number of weeks, such complications might be avoided. A dose missed by a day or two would not result in a sudden deficiency of adrenal hormone and the fact that a dose had been missed would be known to the person responsible for giving the injection. (2) When prednisolone is given by mouth, the stomach, duodenum, and jejunum absorb a very much higher concentration of the hormone than they normally encounter. The very low incidence of gastric complications encountered during adrenal stimulation therapy (West, 1957) Figure, "A" represents a previously untreated patient with a low blood concentration of circulating adrenal hydrocortisone; "B" represents a similar patient with an average normal concentration; "C" a patient accustomed to 15 mg. oral prednisolone daily; "D" a patient accustomed to 20 mg. daily. The shape of the curve for the effective prednisolone concentration following the intramuscular injection has been deduced partly from clinical and partly from urinary corticosteroid assay findings. It will vary a little from patient to patient, the rate of absorption being no doubt affected by the vascularity of the site of the depot and by any local reaction that may occur. It will be appreciated that to treat patient "D", who is being changed from a high oral dose of prednisolone, the injections will have to be repeated every 4 to 5 days to build up an effective concentration. Patient "C" will be without benefit on the first day but will possibly be maintained on Days 2 and 3. Patient "B" will benefit for about 6 days, and Patient "A" for 2 or 3 days longer.
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INTRAMUSCULAR PREDNISOLONE ACETATE
Case Reports Case 1, a male aged 36, had rheumatoid arthritis for 6 months, and was unable to continue work (he was self-employed).
He was given 80 mg. PAIM once each week for 25 weeks. He was occasionally stiff on Day 7, but otherwise without signs or symptoms of rheumatoid arthritis and able to work full time. He had no digestive disturbance.
Case 2, a female aged 43, had rheumatoid arthritis for 1 year, and had received phenylbutazone 3 x 100 mg. for 1 year. The disease activity was widespread and her grip was too weak for her to continue at work.
She was given 80 mg. PAIM once each week for 30 weeks. She had no symptoms for 20 weeks, but now has some stiffness on Days 6 and 7. She is working normally, and has no digestive disturbance.
Case 3, a male aged 50, had rheumatoid arthritis for 12 years, with a long history of recurrent dyspepsia. He had previously received cortisone and prednisolone for 1 year, and his condition was unsatisfactory on 15 mg. prednisolone by mouth.
He was given 80 to 100 mg. PAIM weekly for 28 weeks, with almost complete relief of symptoms. He is working normally, and has no digestive disturbances.
Case 4, a female aged 46, had rheumatoid arthritis for 9 years, and myxoedema for 4 years. Prednisolone 10 mg. for 1 year had been satisfactory, but there was a previous history of duodenal ulcer.
She was given PAIM 80 to 70 mg. weekly for 25 weeks. She is symptom free, and has no digestive disturbance.
Case 5, a male aged 56, had rheumatoid arthritis for 5 years. Aspirin therapy (in the Aspirin/Cortisone Trial) for 4 years had ended in gross deformity, so that he was unable to work. Adrenal stimulation therapy for 15 months had restored his health and earning capacity.
Because of breathlessness on exertion (chronic bronchitis) he was given PAIM 80 mg. weekly for 13 weeks.
The arthritis was well controlled but breathlessness on exertion returned, and he has now been changed to Triamcinolone.
Case 6, a female aged 61, had rheumatoid arthritis for 11 years, with gross deformity and much pain. Prednisolone 10 mg. orally for 4 months had given major relief but dyspepsia began and in spite of antacid therapy a gastric haemorrhage occurred.
The prednisolone was stopped, and after 2 months of dependence on others for personal needs she was given PAIM 80 mg. weekly for 25 weeks. She is now able to look after herself, and has no dyspepsia.
Case 7, a female aged 55, had rheumatoid arthritis for 7 years. She had received hormone therapy for 5 years, but had developed a duodenal ulcer with persistent symptoms for last 2 years.
She was given PAIM 80 mg. weekly for 25 weeks. The ulcer symptoms went immediately but returned after several weeks. They persisted in spite of all treatment until she went on holiday, when they finally disappeared.
Case 8, a male aged 50, had rheumatoid arthritis for 3j years. The disease was not controlled by aspirin or phenylbutazone, and he was given adrenal stimulation therapy for 15 months followed by 1 year on prednisolone 15 mg. daily. During the prednisolone therapy a gastric ulcer developed and a haemorrhage occurred; the prednisolone was continued but severe pain recurred.
He was given PAIM 40 mg. every other day and later 60 mg. every 4 days for 32 weeks. The gastric symptoms disappeared immediately but dyspepsia recurred after 8 weeks and has recurred intermittently ever since.
Case 9, a female aged 62, had rheumatoid arthritis for 34 years, and myxoedema for 4 years. She had had steroid therapy for 5 years, and a severe relapse occurred while she was on 15 mg. prednisolone.
She was given PAIM 60 mg. every 3 days and later every 4 days for 20 weeks. Recovery was rapid but there was some relapse after 12 weeks. She has no digestive disturbance.
Case 10, a male aged 41, had rheumatoid arthritis for 5 years. He had had steroid therapy for 4j years, and for the last year prednisolone 12-5 to 15 mg. daily.
Weakness, dyspepsia, loss of appetite, and early signs of peripheral neuritis (in the feet and ankles) prompted a change to PAIM 40 mg. daily, which was slowly reduced to 80 mg. weekly for 42 weeks. His strength and appetite are restored, and he is back at work, but latterly epigastric pain of the duodenal ulcer type has recurred intermittently.
Case 11, a female aged 35, had rheumatoid arthritis for 7 years with bronchiectasis. The arthritis was widespread with gross damage in hips and knees. She had had steroid therapy for 4 years, prednisolone 15 mg. daily for the last 2 years, and had experienced recurring nausea and heartburn.
She was given PAIM 60 mg. every 3 days, for 16 weeks. There has been no digestive disturbance in spite of this excessive steroid therapy, which is to be reduced.
Case 12, a female aged 42, had rheumatoid arthritis for 11 years, with recurrent thyrotoxicosis. She had received steroid therapy for 7 years, and had latterly been given 10 to 12-5 mg. prednisolone.
A change to PAIM was made because of repeated attacks of abdominal pain and diarrhoea and loss of appetite. The basal metabolism rate was +25, and she was too stiff to do any housework. She received PAIM 40 mg. every other day slowly reduced to 40 mg. every 4 days for 39 weeks. She recovered rapidly and returned to work. Hypertension developed on the high dose but has fallen with decreasing dosage. On the present dose she has some stiffness on Day 4, but there is no need for anti-thyroid therapy, and no digestive disturbance.
Case 13, a male aged 51, had rheumatoid arthritis for 10 years. The disease was active and widespread 275 group.bmj.com on November 7, 2017 -Published by http://ard.bmj.com/ Downloaded from ANNALS OF THE RHEUMATIC DISEASES with much damage. He had received steroid therapy for 4 years (at a high level but the exact dose is not known). He had suffered prolonged dyspepsia.
He was given PAIM 20 mg. daily for 12 weeks. A major improvement after 4 weeks was followed by a heavy fall and a relapse, and after 12 weeks peripheral neuritis developed. There was no digestive disturbance while he was receiving PAIM.
Case 14, a female aged 45, had rheumatoid arthritis for 9 years. The disease was widespread with gross damage in hips and knees. She had received steroid therapy for 41 years.
PAIM therapy was started during a period of depression; she received 60 mg. every 3 days for 30 
Discussion
It should be emphasized again that most of the patients treated were problem cases gathered together from some 4,000 rheumatoid arthritics treated in recent years. It is apparent that, if one wants or needs to give prednisolone by intramuscular injection over prolonged periods, Deltacortril suspension (Pfizer) is suitable and convenient. The present preparation is a little bulky as it contains only 20 mg. per ml., but more concentrated suspensions that are absorbed at a suitable rate will no doubt be forthcoming. Two preparations of prednisolone containing 100 mg. per ml. have been tried, but they have been found satisfactory in only a minority of patients. In one patient a single injection of 400 mg. remained effective for more than 3 weeks. Preparations of cortisone acetate and of Triamcinolone prepared for intra-articular injection were absorbed too fast by intramuscular injection for weekly maintenance therapy.
Our experience of the difficult patients described above leaves no doubt that intramuscular prednisolone is of real value in preventing or minimizing the gastrointestinal disturbances that occur with oral therapy. The marked improvement in health of Case 16 with a large amyloid liver on changing from oral to intramuscular prednisolone is worthy of note. It will take a year or two to find out whether intramuscular prednisolone will remain effective for a longer time than oral prednisolone. Systemically administered cortisol, produced by adrenal stimulation, certainly remains effective for a much longer period than oral cortisone acetate (West, 1957 
